Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Tables)

v3.22.1
Net Loss per Common Share (Tables)
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Antidilutive Securities Excluded From Computation of Diluted Net Loss per Common Share

The following table represents the potential common shares issuable pursuant to outstanding securities as of the related period end dates that were excluded from the computation of diluted net loss per common share, as their inclusion would have an antidilutive effect:

 

 

As of March 31,

 

 

2022

 

 

2021

 

Unvested RSUs

 

7,932,532

 

 

 

4,900,248

 

Vested and unvested options

 

10,857,620

 

 

 

9,030,928

 

ESPP share purchase rights

 

220,029

 

 

 

164,954

 

Total

 

19,010,181

 

 

 

14,096,130